Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Neuhaus, O; Stüve, O; Archelos, JJ; Hartung, HP.
Putative mechanisms of action of statins in multiple sclerosis--comparison to interferon-beta and glatiramer acetate.
J NEUROL SCI 2005 233: 173-177. Doi: 10.1016/j.jns.2005.03.030
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Co-Autor*innen der Med Uni Graz
Archelos-Garcia Juan-Jose
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Statins are inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase and are widely prescribed as cholesterol-lowering agents. They are promising candidates for future treatment in multiple sclerosis (MS) as they have been shown to exhibit immunomodulatory effects. Recent reports have demonstrated that statins are effective in preventing and reversing chronic and relapsing experimental autoimmune encephalomyelitis (EAE), an animal model of MS. Furthermore, in vitro experiments with human immune cells have documented an immunomodulatory mode of action of statins comparable to that of interferon (IFN)-beta. An open label clinical trial assessing simvastatin in MS revealed a significant decrease in the number and volume of new MRI lesions and a favourable safety profile. This article reviews data thus far present on the putative mechanisms of action of statins in the immunopathogenesis of MS. Furthermore, the role of statins as potential pharmacotherapy for MS is discussed in the context of the mechanisms of approved immunotherapies in MS, namely IFN-beta and glatiramer acetate (GA).
Find related publications in this database (using NLM MeSH Indexing)
Adjuvants, Immunologic - therapeutic use
Clinical Trials - therapeutic use
Enzyme Inhibitors - therapeutic use
Humans - therapeutic use
Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use
Interferon-beta - therapeutic use
Models, Biological - therapeutic use
Multiple Sclerosis - drug therapy
Peptides - therapeutic use

Find related publications in this database (Keywords)
multiple sclerosis
immunotherapy
immunomodulation
statins
interferon-beta
glatiramer acetate
© Med Uni Graz Impressum